( 0 1 0 1 O
DLCO 1 5 1 5 B-clinical_variable
> 6 7 6 7 O
50 8 10 8 10 B-lower_bound
% 10 11 10 11 I-lower_bound
of 12 14 12 14 O
predicted 15 24 15 24 O
) 24 25 24 25 O

( 0 1 26 27 B-clinical_variable
MUGA 1 5 27 31 I-clinical_variable
) 5 6 31 32 I-clinical_variable
LVEF 7 11 33 37 I-clinical_variable
> 12 13 38 39 O
45 13 15 39 41 B-lower_bound
% 15 16 41 42 I-lower_bound
) 16 17 42 43 O

( 0 1 44 45 O
PO2 1 4 45 48 B-clinical_variable
< 5 6 49 50 O
80 6 8 50 52 B-upper_bound
) 8 9 52 53 O

Acute 0 5 54 59 B-cancer
myeloid 6 13 60 67 I-cancer
leukemia 14 22 68 76 I-cancer
( 23 24 77 78 I-cancer
AML 24 27 78 81 I-cancer
) 27 28 81 82 I-cancer

All 0 3 83 86 O
children 4 12 87 95 O
and 13 16 96 99 O
adults 17 23 100 106 O
less 24 28 107 111 O
than 29 33 112 116 O
the 34 37 117 120 O
age 38 41 121 124 B-age
of 42 44 125 127 O
70 45 47 128 130 B-upper_bound
with 48 52 131 135 O
AML 53 56 136 139 O
who 57 60 140 143 O
have 61 65 144 148 O
achieved 66 74 149 157 O
a 75 76 158 159 O
first 77 82 160 165 O
or 83 85 166 168 O
second 86 92 169 175 O
bone 93 97 176 180 O
marrow 98 104 181 187 O
remission 105 114 188 197 O

Allogeneic 0 10 198 208 B-treatment
transplant 11 21 209 219 I-treatment
with 22 26 220 224 I-treatment
an 27 29 225 227 I-treatment
HLA 30 33 228 231 I-treatment
- 33 34 231 232 I-treatment
identical 34 43 232 241 I-treatment
sibling 44 51 242 249 I-treatment
will 52 56 250 254 O
be 57 59 255 257 O
recommended 60 71 258 269 O
for 72 75 270 273 O
patients 76 84 274 282 O
< 85 86 283 284 O
55 86 88 284 286 B-upper_bound
years 89 94 287 292 I-upper_bound

Children 0 8 293 301 O
under 9 14 302 307 O
the 15 18 308 311 O
age 19 22 312 315 B-age
of 23 25 316 318 O
two 26 29 319 322 B-upper_bound

Eastern 0 7 323 330 B-clinical_variable
Cooperative 8 19 331 342 I-clinical_variable
Oncology 20 28 343 351 I-clinical_variable
Group 29 34 352 357 I-clinical_variable
( 35 36 358 359 I-clinical_variable
ECOG 36 40 359 363 I-clinical_variable
) 40 41 363 364 I-clinical_variable
Performance 42 53 365 376 I-clinical_variable
status 54 60 377 383 I-clinical_variable
: 60 61 383 384 O
0 62 63 385 386 B-lower_bound
or 64 66 387 389 O
1 67 68 390 391 B-upper_bound

Patients 0 8 392 400 O
can 9 12 401 404 O
also 13 17 405 409 O
be 18 20 410 412 O
deemed 21 27 413 419 O
not 28 31 420 423 O
eligible 32 40 424 432 O
for 41 44 433 436 O
transplant 45 55 437 447 B-treatment
because 56 63 448 455 O
of 64 66 456 458 O
specific 67 75 459 467 O
organ 76 81 468 473 O
toxicity 82 90 474 482 O

Patients 0 8 483 491 O
must 9 13 492 496 O
be 14 16 497 499 O
free 17 21 500 504 O
of 22 24 505 507 O
active 25 31 508 514 O
or 32 34 515 517 O
ongoing 35 42 518 525 O
ischemic 43 51 526 534 O
or 52 54 535 537 O
degenerative 55 67 538 550 B-chronic_disease
CNS 68 71 551 554 I-chronic_disease
disease 72 79 555 562 I-chronic_disease
and 80 83 563 566 O
no 84 86 567 569 O
active 87 93 570 576 O
or 94 96 577 579 O
resistant 97 106 580 589 O
CNS 107 110 590 593 B-cancer
leukemia 111 119 594 602 I-cancer

Patients 0 8 603 611 O
must 9 13 612 616 O
have 14 18 617 621 O
no 19 21 622 624 O
significant 22 33 625 636 O
obstructive 34 45 637 648 B-chronic_disease
airways 46 53 649 656 I-chronic_disease
disease 54 61 657 664 I-chronic_disease
or 62 64 665 667 O
resting 65 72 668 675 O
hypoxemia 73 82 676 685 B-chronic_disease

Patients 0 8 686 694 O
must 9 13 695 699 O
undergo 14 21 700 707 O
peripheral 22 32 708 718 B-treatment
blood 33 38 719 724 I-treatment
stem 39 43 725 729 I-treatment
cell 44 48 730 734 I-treatment
collection 49 59 735 745 I-treatment
or 60 62 746 748 O
marrow 63 69 749 755 B-treatment
harvest 70 77 756 763 I-treatment
while 78 83 764 769 O
in 84 86 770 772 O
remission 87 96 773 782 O
and 97 100 783 786 O
must 101 105 787 791 O
not 106 109 792 795 O
be 110 112 796 798 O
expected 113 121 799 807 O
to 122 124 808 810 O
have 125 129 811 815 O
better 130 136 816 822 O
outcomes 137 145 823 831 O
with 146 150 832 836 O
allogeneic 151 161 837 847 B-treatment
transplantation 162 177 848 863 I-treatment

Patients 0 8 864 872 O
who 9 12 873 876 O
can 13 16 877 880 O
not 16 19 880 883 O
receive 20 27 884 891 O
total 28 33 892 897 B-treatment
body 34 38 898 902 I-treatment
irradiation 39 50 903 914 I-treatment
( 51 52 915 916 I-treatment
TBI 52 55 916 919 I-treatment
) 55 56 919 920 I-treatment
( 57 58 921 922 O
for 58 61 922 925 O
example 62 69 926 933 O
those 70 75 934 939 O
with 76 80 940 944 O
prior 81 86 945 950 B-treatment
radiation 87 96 951 960 I-treatment
therapy 97 104 961 968 I-treatment
) 104 105 968 969 O
will 106 110 970 974 O
also 111 115 975 979 O
receive 116 123 980 987 O
the 124 127 988 991 O
Bu 128 130 992 994 B-treatment
/ 130 131 994 995 I-treatment
CY 131 133 995 997 I-treatment
conditioning 134 146 998 1010 I-treatment

Patients 0 8 1011 1019 O
with 9 13 1020 1024 O
cytogenetic 14 25 1025 1036 B-chronic_disease
abnormalities 26 39 1037 1050 I-chronic_disease
suggesting 40 50 1051 1061 O
an 51 53 1062 1064 O
improved 54 62 1065 1073 O
prognosis 63 72 1074 1083 O
[ 73 74 1084 1085 O
t(8:21 74 80 1085 1091 B-cancer
) 80 81 1091 1092 I-cancer
, 81 82 1092 1093 O
t(15;17 83 90 1094 1101 B-cancer
) 90 91 1101 1102 I-cancer
and 92 95 1103 1106 O
inv(16 96 102 1107 1113 O
) 102 103 1113 1114 O
] 103 104 1114 1115 O
will 105 109 1116 1120 O
be 110 112 1121 1123 O
eligible 113 121 1124 1132 O
for 122 125 1133 1136 O
transplantation 126 141 1137 1152 B-treatment
in 142 144 1153 1155 O
first 145 150 1156 1161 O
remission 151 160 1162 1171 O

The 0 3 1172 1175 O
patient 4 11 1176 1183 O
must 12 16 1184 1188 O
be 17 19 1189 1191 O
free 20 24 1192 1196 O
of 25 27 1197 1199 O
symptoms 28 36 1200 1208 O
of 37 39 1209 1211 O
uncontrolled 40 52 1212 1224 B-chronic_disease
cardiac 53 60 1225 1232 I-chronic_disease
disease 61 68 1233 1240 I-chronic_disease
, 68 69 1240 1241 O
and 70 73 1242 1245 O
must 74 78 1246 1250 O
not 79 82 1251 1254 O
have 83 87 1255 1259 O
compromised 88 99 1260 1271 O
cardiac 100 107 1272 1279 O
function 108 116 1280 1288 O
detected 117 125 1289 1297 O
by 126 128 1298 1300 O
ECHO 129 133 1301 1305 B-treatment
or 134 136 1306 1308 O
by 137 139 1309 1311 O
gated 140 145 1312 1317 B-treatment
cardiac 146 153 1318 1325 I-treatment
blood 154 159 1326 1331 I-treatment
flow 160 164 1332 1336 I-treatment
scan 165 169 1337 1341 I-treatment

The 0 3 1342 1345 O
patient 4 11 1346 1353 O
must 12 16 1354 1358 O
have 17 21 1359 1363 O
a 22 23 1364 1365 O
corrected 24 33 1366 1375 O
creatinine 34 44 1376 1386 B-clinical_variable
clearance 45 54 1387 1396 I-clinical_variable
> 55 56 1397 1398 O
50 56 58 1398 1400 B-lower_bound
% 58 59 1400 1401 I-lower_bound
of 60 62 1402 1404 O
normal 63 69 1405 1411 O

The 0 3 1412 1415 O
total 4 9 1416 1421 B-clinical_variable
serum 10 15 1422 1427 I-clinical_variable
bilirubin 16 25 1428 1437 I-clinical_variable
< 26 27 1438 1439 O
2.5 28 31 1440 1443 B-upper_bound
mg 32 34 1444 1446 I-upper_bound
/ 34 35 1446 1447 I-upper_bound
dL 35 37 1447 1449 I-upper_bound
; 37 38 1449 1450 O
ALT 39 42 1451 1454 B-clinical_variable
< 43 44 1455 1456 O
2 44 45 1456 1457 B-upper_bound
x 46 47 1458 1459 I-upper_bound
upper 48 53 1460 1465 I-upper_bound
limit 54 59 1466 1471 I-upper_bound
of 60 62 1472 1474 I-upper_bound
normal 63 69 1475 1481 I-upper_bound

acceptable 0 10 1482 1492 O
diffusion 11 20 1493 1502 B-treatment
capacity 21 29 1503 1511 I-treatment

children 0 8 1512 1520 O
under 9 14 1521 1526 O
the 15 18 1527 1530 O
age 19 22 1531 1534 B-age
of 23 25 1535 1537 O
two 26 29 1538 1541 B-upper_bound

patient 0 7 1542 1549 O
refuses 8 15 1550 1557 O
allogeneic 16 26 1558 1568 B-treatment
transplant 27 37 1569 1579 I-treatment

patients 0 8 1580 1588 O
with 9 13 1589 1593 O
pre 14 17 1594 1597 O
- 17 18 1597 1598 O
existing 18 26 1598 1606 O
compromise 27 37 1607 1617 O
to 38 40 1618 1620 O
the 41 44 1621 1624 O
heart 45 50 1625 1630 B-chronic_disease
, 50 51 1630 1631 O
lungs 52 57 1632 1637 B-chronic_disease
, 57 58 1637 1638 O
kidney 59 65 1639 1645 B-chronic_disease
, 65 66 1645 1646 O
CNS 67 70 1647 1650 B-chronic_disease
or 71 73 1651 1653 O
liver 74 79 1654 1659 B-chronic_disease

receive 0 7 1660 1667 O
Busulfan 8 16 1668 1676 B-treatment
/ 16 17 1676 1677 I-treatment
Cyclophosphamide 17 33 1677 1693 I-treatment
( 34 35 1694 1695 I-treatment
Bu 35 37 1695 1697 I-treatment
/ 37 38 1697 1698 I-treatment
Cy 38 40 1698 1700 I-treatment
) 40 41 1700 1701 I-treatment
conditioning 42 54 1702 1714 O
as 55 57 1715 1717 O
the 58 61 1718 1721 O
preparative 62 73 1722 1733 O
regimen 74 81 1734 1741 O
in 82 84 1742 1744 O
order 85 90 1745 1750 O
to 91 93 1751 1753 O
obviate 94 101 1754 1761 O
deleterious 102 113 1762 1773 O
effects 114 121 1774 1781 O
of 122 124 1782 1784 O
radiation 125 134 1785 1794 B-treatment
at 135 137 1795 1797 O
this 138 142 1798 1802 O
age 143 146 1803 1806 B-age

